Friday 6 November 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.

Revenue: −7.01%
EPS: −101.0%
Free cash flow: +561.9%
Total debt: −90.1%

Quarter to September 2026, against a year earlier

86.56 2.79 −3.12%

Follow SOLV

Alert me

Market cap: $14.8B
P/E: 97.3×
Fwd P/E: 47.7×
Dividend yield: —
F-score: 5/9
Altman Z: 2.22
Beneish M: −2.07
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Solventum Corporation (SOLV) Price to free cash flow

Alert me on Price to free cash flow

Solventum Corporation has no meaningful price to free cash flow: its trailing twelve-month free cash flow is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 299× (November 2025) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SOLV/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Solventum Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SOLV/metrics/price-to-free-cash-flow">Solventum Corporation (SOLV) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	0.0×	—
FY2024	14.2×	67.17%
FY2023	8.5×	0.00%
FY2022	8.5×	—

Period	Price to free cash flow	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
11 more quarters	Free account

Against its own ten years

Low 0.0× High 299×

Ten-year median 7.8×

Current reading's percentile 33

Company	Price to free cash flow
SOLV Solventum Corporation	n/m
BAX Baxter International Inc. compare	11.6×
ALGN Align Technology, Inc. compare	16.8×
COO The Cooper Companies, Inc. compare	18.1×
AVTR Avantor, Inc. compare	23.3×
ATR AptarGroup, Inc. compare	31.0×
BLCO Bausch + Lomb Corporation compare	31.4×
WST West Pharmaceutical Services, Inc. compare	61.5×
RGEN Repligen Corporation compare	170×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Solventum Corporation (SOLV) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SOLV

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SOLV

Stockrow Weekly